Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma

BACKGROUND: The validation of novel diagnostic, prognostic and predictive biomarkers in cancer is crucial for optimizing the choice and efficacy of personalized therapies. The aim of this study was to determine the epidermal growth factor receptor (EGFR), epidermal growth factor receptor variant III...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diagn Pathol
Autors principals: Wang, Li, Wu, Huanwen, Wang, Lili, Lu, Junliang, Duan, Huanli, Liu, Xuguang, Liang, Zhiyong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938900/
https://ncbi.nlm.nih.gov/pubmed/27391842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0512-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars